01 · EBM Build
Electron Beam Melting
Layer-by-layer build of Ti-6Al-4V ELI in vacuum. 50–100 µm layer thickness, 60 kV electron beam, 700 °C pre-heat.
Patient-Matched · Additive Manufacturing · Regenerative
The world's first clinically validated, patient-matched titanium cranial implant.
Excellent MedTech pioneers personalised 3D-printed titanium reconstruction and regenerative medicine — bridging the gap from form to function to regeneration.
< 2%Total complication rate
5,000+Clinical cases delivered
60+Patents & IP rights
NMPAClass III approved
Trusted by 500+ hospitals & clinical partners
Fourth Military Medical University
Southern Medical University
Shenzhen Second People's Hospital
Beijing Tiantan Hospital
Huashan Hospital
Xuanwu Hospital
Why Excellent MedTech
From "fill the hole" to "regenerate the bone".
Three generations of implant technology, one patient. We deliver anatomical match, biomechanical strength, and a long-term pathway to regeneration — the first PSI implant validated by a large-cohort prospective clinical study.
01 · Form
Perfect anatomical match
CT/MRI 3D reconstruction plus biomimetic dual-surface design restores natural cranial curvature 1-to-1 — sub-millimetre accuracy on first placement.
Learn more →
02 · Function
Outstanding mechanical & biological performance
Ti-6Al-4V ELI with gradient-optimised porous micro-architecture. 1,400 N compressive strength, ≥ 5 million cycle fatigue, native TiO₂ osseointegration.
Learn more →
03 · Regeneration
A platform built for the future of tissue repair
Beyond reconstruction: protein-engineering (ME-Regen®) and tissue engineering (Cell home®) extend the same platform into in-situ regeneration.
Learn more →0+Clinical cases delivered
0+Hospital partners
0+Patents & IP rights
0Invention patents granted
Clinical Evidence
The data that changes the conversation.
In head-to-head literature comparisons, our patient-matched implants deliver total complication rates one-fifth of conventional mesh and one-tenth of PEEK plates.
Total complication rate
Source: large-cohort prospective clinical study vs. peer-reviewed literature controls.
Infection rate
Lower infection = fewer re-operations, less antibiotic exposure, lower total cost of care.
Re-operation (critical failure)
Validated across 5,000+ implants delivered to date.
Three Technology Platforms
A single R&D engine. Three revolutions in patient care.
Our research institute operates three integrated platforms — each addressing a different layer of the human tissue repair problem.
Additive manufacturing of personalised implants
From 30,000+ clinical cases, our deep-learning models achieve 95%+ bionic match — and ship it as a Class III implant.
- Electron Beam Melting of Ti-6Al-4V ELI
- Gradient-optimised porous micro-architecture
- Patient-specific 1:1 anatomical reconstruction
- Validated for cranial, maxillofacial, orthopaedic
Nobel-grade controlled release for in-situ regeneration
Microgram-level precision protein delivery extends therapeutic retention to 2–4 weeks — the holy grail of regenerative pharmacology.
- Low-dose, long-acting protein release
- Tunable release kinetics
- Bone, skin, vascular, neural applications
- Closed-loop R&D; pilot & clinical coming
In-vivo tissue engineering & organ transplant
Beyond repair: building consistent, functional human tissue for transplant — solving donor ethics and shortage in one stroke.
- In-vitro and in-vivo tissue manufacturing
- Bone, cartilage, skin, vascular, neural
- Eliminate donor-site morbidity
- Pilot scale; clinical coming
From CT to Surgery
Five stages. Five to seven working days.
You send the CT. We return a sterile, ready-to-implant patient-matched prosthesis. Lead time 5–7 working days (3 days expedited).
1
Clinical Intake
Surgeon sends DICOM + defect description. Medical engineer responds within 24 h.
2
Image & Design
3D reconstruction → biomimetic design → gradient optimisation → FEA validation.
3
Medicine-Engineering Interaction
Surgeon & engineer sign off on the design — no intra-operative "discovery".
4
Precision Manufacturing
Electron Beam Melting, post-processing, 100% CMM inspection, double-pouch sterile pack.
5
Direct Logistics
DHL / FedEx to hospital. ±10% backup implant shipped together.
Featured Product
Additive Manufacturing Patient-Matched Skull Reconstruction System
Class III implant system designed for cranial defect repair and reconstruction. Models DLZ04 & DLZ05. Size range 30–200 mm. Made of medical-grade Ti-6Al-4V ELI titanium alloy, manufactured by Electron Beam Melting.
- Biomimetic dual-surface: porous for bone ingrowth, smooth for soft tissue
- 1,400 N compressive strength · 5×10⁶ cycle fatigue
- 1:1 patient-specific geometry from CT / MRI DICOM
- CT-clear imaging · MRI-safe · Non-magnetic
Global Reach
Engineered in Shenzhen. Available in 40+ countries.
From Tier-1 Chinese academic hospitals to leading European neurosurgical centres, our patient-matched implants are designed to meet the most stringent international standards.
CHINA
Tier-1 academic hospitals
Beijing Tiantan, Huashan, Xuanwu, FMMU, Southern Medical, Shenzhen Second People's.
EUROPE
CE-MDR in progress
Charité Berlin, MHH Hannover, LMU Munich, AP-HP Paris, Niguarda, Vall d'Hebron.
U.S.
FDA 510(k) scoping
Engagement with FDA CDRH. Targeting Class II 882.5320 (GWO) or equivalent.
MDSAP
5 markets, 1 audit
Single audit for US, Canada, Australia, Japan, Brazil — in scoping.
Regulatory & Quality
Built to the highest global standard.
Our quality system is engineered for the world's most demanding medical device regulators — from NMPA Class III to CE-MDR and FDA 510(k).
Granted
NMPA Class III
国械注准 20263130176
Certified
ISO 13485
QMS for medical devices
Certified
GMP
Production of Class III devices
In progress
CE-MDR
Class III, Rule 8
News & Insights
All news →
Latest from Excellent MedTech
Excellent MedTech to exhibit at MEDICA 2026 (Düsseldorf)
Hall 16 / Booth G42 — meet our team and see the latest patient-matched cranial implant technology in person.
Excellent MedTech initiates Series A+ to scale global manufacturing
Proceeds to fund 5,000 m² GMP manufacturing centre and accelerate international regulatory submissions.
Large-cohort prospective study confirms < 2% total complication rate
5,000+ implant dataset continues to support the long-term safety of patient-matched titanium cranioplasty.
Case Studies & Real Outcomes
5,000+ patients. Real stories. Real data.
Every implant we ship has a patient and a surgeon behind it. Here is what the workflow looks like in practice — and what the 6-month follow-up data says.
< 2%
Total complication rate
0%
Critical failure re-operation
5,000+
Patients across the dataset
50+
Clinical trial sites
Industry-University Collaboration
The partnerships that built this platform.
Selected milestones from the partnership with Shenzhen University of Technology (SZTU) and other research collaborators.
SZTU & Excellent MedTech release 3D-printed personalised implant results
Joint development presented at SZTU's Education-Science-Talent Integration Ecosystem Conference.
Industry News
National medical device certification achieved
Joint research with Prof. Zhang Peng achieves national medical device certification. Covered by Shenzhen Special Zone Daily.
National Certification
World's first large-cohort validated implant
First PSI CMF implant validated by a large-cohort prospective clinical study. Joint publication with SZTU.
Industry First
3,000-case milestone reached
Three thousand patient-matched skull reconstruction systems delivered across China.
Milestone
NMPA Class III approval
国械注准 20263130176 — Class III PSI cranial implant approved by NMPA.
Granted
2020 Medical Device Innovation Vitality List
Recognised by 动脉网 (VCBeat) as one of the most innovative growth-stage medical device companies.
Award
Bring patient-matched reconstruction to your hospital.
Join 500+ clinical partners worldwide. Talk to our team about distribution, OEM/ODM, or co-development. We respond within 24 hours.